174 related articles for article (PubMed ID: 36320323)
21. BHLHE40 plays a pathological role in pre-eclampsia through upregulating SNX16 by transcriptional inhibition of miR-196a-5p.
Mi C; Ye B; Gao Z; Du J; Li R; Huang D
Mol Hum Reprod; 2020 Jul; 26(7):532-548. PubMed ID: 32579212
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-196a promotes renal cancer cell migration and invasion by targeting BRAM1 to regulate SMAD and MAPK signaling pathways.
Cui J; Yuan Y; Shanmugam MK; Anbalagan D; Tan TZ; Sethi G; Kumar AP; Lim LHK
Int J Biol Sci; 2021; 17(15):4254-4270. PubMed ID: 34803496
[No Abstract] [Full Text] [Related]
23. Upregulation of microRNA-196a improves cognitive impairment and alleviates neuronal damage in hippocampus tissues of Alzheimer's disease through downregulating LRIG3 expression.
Yang K; Feng S; Ren J; Zhou W
J Cell Biochem; 2019 Oct; 120(10):17811-17821. PubMed ID: 31119777
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of microRNA-196a inhibits stem cell self-renewal ability and stemness in non-small-cell lung cancer through upregulating GPX3 expression.
Liu Q; Bai W; Huang F; Tang J; Lin X
Int J Biochem Cell Biol; 2019 Oct; 115():105571. PubMed ID: 31352088
[TBL] [Abstract][Full Text] [Related]
25. Long Noncoding RNA H19 Induces Neuropathic Pain by Upregulating Cyclin-Dependent Kinase 5-Mediated Phosphorylation of cAMP Response Element Binding Protein.
Li K; Jiao Y; Ren X; You D; Cao R
J Pain Res; 2020; 13():2113-2124. PubMed ID: 32903807
[TBL] [Abstract][Full Text] [Related]
26. MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.
Yang G; Han D; Chen X; Zhang D; Wang L; Shi C; Zhang W; Li C; Chen X; Liu H; Zhang D; Kang J; Peng F; Liu Z; Qi J; Gao X; Ai J; Shi C; Zhao S
Neuro Oncol; 2014 May; 16(5):652-61. PubMed ID: 24463357
[TBL] [Abstract][Full Text] [Related]
27. Capzb2 PROTEIN EXPRESSION IN THE BRAINS OF PATIENTS DIAGNOSED WITH ALZHEIMER'S DISEASE AND HUNTINGTON'S DISEASE.
Vanderburg CR; Davis DA; Diamond RE; Kao PF; Delalle I
Transl Neurosci; 2010 Mar; 1(1):55-58. PubMed ID: 29662700
[TBL] [Abstract][Full Text] [Related]
28. The Long Noncoding RNA-H19 Mediates the Progression of Fibrosis from Acute Kidney Injury to Chronic Kidney Disease by Regulating the miR-196a/Wnt/β-Catenin Signaling.
Dong X; Cao R; Li Q; Yin L
Nephron; 2022; 146(2):209-219. PubMed ID: 34818249
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of microRNA-196a attenuates ischemic brain injury in rats by directly targeting HMGA1.
Zhang DL; Liu X; Wang Q; Li N; Wu SH; Wang C
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):740-748. PubMed ID: 30720182
[TBL] [Abstract][Full Text] [Related]
30. Implication of β2-adrenergic receptor and miR-196a correlation in neurite outgrowth of LNCaP prostate cancer cells.
Guerriero I; Ramberg H; Sagini K; Ramirez-Garrastacho M; Taskén KA; Llorente A
PLoS One; 2021; 16(6):e0253828. PubMed ID: 34191854
[TBL] [Abstract][Full Text] [Related]
31. Negative regulation of lncRNA GAS5 by miR-196a inhibits esophageal squamous cell carcinoma growth.
Wang K; Li J; Xiong G; He G; Guan X; Yang K; Bai Y
Biochem Biophys Res Commun; 2018 Jan; 495(1):1151-1157. PubMed ID: 29170131
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of tissue and circulating levels of IMP3 in prostate cancer.
Szarvas T; Tschirdewahn S; Niedworok C; Kramer G; Sevcenco S; Reis H; Shariat SF; Rübben H; vom Dorp F
Int J Cancer; 2014 Oct; 135(7):1596-604. PubMed ID: 24615121
[TBL] [Abstract][Full Text] [Related]
34. The emerging role of long non-coding RNAs, microRNAs, and an accelerated epigenetic age in Huntington's disease.
Ghafouri-Fard S; Khoshbakht T; Hussen BM; Taheri M; Ebrahimzadeh K; Noroozi R
Front Aging Neurosci; 2022; 14():987174. PubMed ID: 36185471
[TBL] [Abstract][Full Text] [Related]
35. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
37. Altered microRNA expression in animal models of Huntington's disease and potential therapeutic strategies.
Martinez B; Peplow PV
Neural Regen Res; 2021 Nov; 16(11):2159-2169. PubMed ID: 33818488
[TBL] [Abstract][Full Text] [Related]
38. LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205.
Yang W; Hong L; Xu X; Wang Q; Huang J; Jiang L
Tumour Biol; 2017 Jul; 39(7):1010428317711315. PubMed ID: 28671039
[TBL] [Abstract][Full Text] [Related]
39. IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65.
Bhargava S; Visvanathan A; Patil V; Kumar A; Kesari S; Das S; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
Oncotarget; 2017 Jun; 8(25):40469-40485. PubMed ID: 28465487
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.
Ban JJ; Chung JY; Lee M; Im W; Kim M
Biochem Biophys Res Commun; 2017 Jun; 488(2):316-321. PubMed ID: 28495533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
